These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 16265257

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.
    Pereira L, Andrikopoulos K, Tian J, Lee SY, Keene DR, Ono R, Reinhardt DP, Sakai LY, Biery NJ, Bunton T, Dietz HC, Ramirez F.
    Nat Genet; 1997 Oct; 17(2):218-22. PubMed ID: 9326947
    [Abstract] [Full Text] [Related]

  • 3. Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.
    Gambarin FI, Favalli V, Serio A, Regazzi M, Pasotti M, Klersy C, Dore R, Mannarino S, Viganò M, Odero A, Amato S, Tavazzi L, Arbustini E.
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):354-62. PubMed ID: 19430350
    [Abstract] [Full Text] [Related]

  • 4. miR-29b participates in early aneurysm development in Marfan syndrome.
    Merk DR, Chin JT, Dake BA, Maegdefessel L, Miller MO, Kimura N, Tsao PS, Iosef C, Berry GJ, Mohr FW, Spin JM, Alvira CM, Robbins RC, Fischbein MP.
    Circ Res; 2012 Jan 20; 110(2):312-24. PubMed ID: 22116819
    [Abstract] [Full Text] [Related]

  • 5. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.
    Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC.
    Science; 2006 Apr 07; 312(5770):117-21. PubMed ID: 16601194
    [Abstract] [Full Text] [Related]

  • 6. [Diagnosis and options for reconstructive heart valve surgery in the Marfan syndrome].
    Bernhardt A, Treede H, Rybczynski M, Sheikzadeh S, Meinertz T, Reichenspurner H, Kodolitsch Y.
    Kardiologiia; 2011 Apr 07; 51(8):85-90. PubMed ID: 21942965
    [Abstract] [Full Text] [Related]

  • 7. Marfan's syndrome and other disorders of fibrillin.
    Francke U, Furthmayr H.
    N Engl J Med; 1994 May 12; 330(19):1384-5. PubMed ID: 8152453
    [No Abstract] [Full Text] [Related]

  • 8. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1.
    Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T, Biery NJ, Dietz HC, Sakai LY, Ramirez F.
    Proc Natl Acad Sci U S A; 1999 Mar 30; 96(7):3819-23. PubMed ID: 10097121
    [Abstract] [Full Text] [Related]

  • 9. Marfan syndrome revisited: From genetics to the clinic.
    Coelho SG, Almeida AG.
    Rev Port Cardiol (Engl Ed); 2020 Apr 30; 39(4):215-226. PubMed ID: 32439107
    [Abstract] [Full Text] [Related]

  • 10. The pathogenesis of aortopathy in Marfan syndrome and related diseases.
    Jones JA, Ikonomidis JS.
    Curr Cardiol Rep; 2010 Mar 30; 12(2):99-107. PubMed ID: 20425163
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New insights into the structure, assembly and biological roles of 10-12 nm connective tissue microfibrils from fibrillin-1 studies.
    Jensen SA, Handford PA.
    Biochem J; 2016 Apr 01; 473(7):827-38. PubMed ID: 27026396
    [Abstract] [Full Text] [Related]

  • 13. The molecular genetics of Marfan syndrome and related disorders.
    Robinson PN, Arteaga-Solis E, Baldock C, Collod-Béroud G, Booms P, De Paepe A, Dietz HC, Guo G, Handford PA, Judge DP, Kielty CM, Loeys B, Milewicz DM, Ney A, Ramirez F, Reinhardt DP, Tiedemann K, Whiteman P, Godfrey M.
    J Med Genet; 2006 Oct 01; 43(10):769-87. PubMed ID: 16571647
    [Abstract] [Full Text] [Related]

  • 14. Overexpression of transforming growth factor-beta is associated with increased hyaluronan content and impairment of repair in Marfan syndrome aortic aneurysm.
    Nataatmadja M, West J, West M.
    Circulation; 2006 Jul 04; 114(1 Suppl):I371-7. PubMed ID: 16820603
    [Abstract] [Full Text] [Related]

  • 15. Marfan's syndrome.
    Judge DP, Dietz HC.
    Lancet; 2005 Dec 03; 366(9501):1965-76. PubMed ID: 16325700
    [Abstract] [Full Text] [Related]

  • 16. Determination of the molecular basis of Marfan syndrome: a growth industry.
    Byers PH.
    J Clin Invest; 2004 Jul 03; 114(2):161-3. PubMed ID: 15254580
    [Abstract] [Full Text] [Related]

  • 17. Medicine. Old drug, new hope for Marfan syndrome.
    Travis J.
    Science; 2006 Apr 07; 312(5770):36-7. PubMed ID: 16601163
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mutations of extracellular matrix components in vascular disease.
    Ramirez F, Pereira L.
    Ann Thorac Surg; 1999 Jun 07; 67(6):1857-8; discussion 1868-70. PubMed ID: 10391325
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.